SMTL ID : 1piv.3 (4 other biounits)

BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-6-6-6-6-mer

Ligands

6 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3 (SUBUNIT VP1)(Non-covalent)

ILE-SER-GLU-VAL.1: 4 residues within 4Å: Chain D: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain D Hydrogen bonds: D:A.2, D:Q.3, D:V.4, D:V.4 ILE-SER-GLU-VAL.4: 4 residues within 4Å: Chain H: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain H Hydrogen bonds: H:A.2, H:Q.3, H:V.4, H:V.4 ILE-SER-GLU-VAL.7: 4 residues within 4Å: Chain L: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain L Hydrogen bonds: L:A.2, L:Q.3, L:V.4, L:V.4 ILE-SER-GLU-VAL.10: 4 residues within 4Å: Chain P: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain P Hydrogen bonds: P:A.2, P:Q.3, P:V.4, P:V.4 ILE-SER-GLU-VAL.13: 4 residues within 4Å: Chain T: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain T Hydrogen bonds: T:A.2, T:Q.3, T:V.4, T:V.4 ILE-SER-GLU-VAL.16: 4 residues within 4Å: Chain X: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain X Hydrogen bonds: X:A.2, X:Q.3, X:V.4, X:V.4

6 x W71: 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE(Non-covalent)

W71.2: 17 residues within 4Å: Chain A: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240 Chain C: A.24 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:Y.111, A:F.133, A:Y.158, A:Y.158, A:Y.158, A:I.193, A:V.195, A:V.195, A:F.237, A:F.237, A:F.237, A:L.240 pi-Stacking: A:Y.111 W71.5: 17 residues within 4Å: Chain E: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240 Chain G: A.24 13 PLIP interactions: 13 interactions with chain E Hydrophobic interactions: E:Y.111, E:F.133, E:Y.158, E:Y.158, E:Y.158, E:I.193, E:V.195, E:V.195, E:F.237, E:F.237, E:F.237, E:L.240 pi-Stacking: E:Y.111 W71.8: 17 residues within 4Å: Chain I: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240 Chain K: A.24 13 PLIP interactions: 13 interactions with chain I Hydrophobic interactions: I:Y.111, I:F.133, I:Y.158, I:Y.158, I:Y.158, I:I.193, I:V.195, I:V.195, I:F.237, I:F.237, I:F.237, I:L.240 pi-Stacking: I:Y.111 W71.11: 17 residues within 4Å: Chain M: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240 Chain O: A.24 13 PLIP interactions: 13 interactions with chain M Hydrophobic interactions: M:Y.111, M:F.133, M:Y.158, M:Y.158, M:Y.158, M:I.193, M:V.195, M:V.195, M:F.237, M:F.237, M:F.237, M:L.240 pi-Stacking: M:Y.111 W71.14: 17 residues within 4Å: Chain Q: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240 Chain S: A.24 13 PLIP interactions: 13 interactions with chain Q Hydrophobic interactions: Q:Y.111, Q:F.133, Q:Y.158, Q:Y.158, Q:Y.158, Q:I.193, Q:V.195, Q:V.195, Q:F.237, Q:F.237, Q:F.237, Q:L.240 pi-Stacking: Q:Y.111 W71.17: 17 residues within 4Å: Chain U: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240 Chain W: A.24 13 PLIP interactions: 13 interactions with chain U Hydrophobic interactions: U:Y.111, U:F.133, U:Y.158, U:Y.158, U:Y.158, U:I.193, U:V.195, U:V.195, U:F.237, U:F.237, U:F.237, U:L.240 pi-Stacking: U:Y.111

6 x MYR: MYRISTIC ACID(Covalent)

MYR.3: 8 residues within 4Å: Chain D: G.1, A.2, Y.31 Chain H: V.4, T.27, I.29, Y.31 Ligands: MYR.6 2 PLIP interactions: 1 interactions with chain D, 1 interactions with chain H Hydrogen bonds: D:A.2, H:T.27 MYR.6: 4 residues within 4Å: Chain H: G.1, A.2, Y.31 Ligands: MYR.3 1 PLIP interactions: 1 interactions with chain H Hydrogen bonds: H:A.2 MYR.9: 4 residues within 4Å: Chain L: G.1, A.2, Y.31 Ligands: MYR.12 1 PLIP interactions: 1 interactions with chain L Hydrogen bonds: L:A.2 MYR.12: 8 residues within 4Å: Chain L: V.4, T.27, I.29, Y.31 Chain P: G.1, A.2, Y.31 Ligands: MYR.9 2 PLIP interactions: 1 interactions with chain P, 1 interactions with chain L Hydrogen bonds: P:A.2, L:T.27 MYR.15: 8 residues within 4Å: Chain T: G.1, A.2, Y.31 Chain X: V.4, T.27, I.29, Y.31 Ligands: MYR.18 2 PLIP interactions: 1 interactions with chain X, 1 interactions with chain T Hydrogen bonds: X:T.27, T:A.2 MYR.18: 4 residues within 4Å: Chain X: G.1, A.2, Y.31 Ligands: MYR.15 1 PLIP interactions: 1 interactions with chain X Hydrogen bonds: X:A.2

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hiremath, C.N. et al., Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr.,Sect.D (1995)

Release Date

1995-06-03

Peptides

POLIOVIRUS TYPE 3 (SUBUNIT VP1): AEIMQU
POLIOVIRUS TYPE 3 (SUBUNIT VP2): BFJNRV
POLIOVIRUS TYPE 3 (SUBUNIT VP3): CGKOSW
POLIOVIRUS TYPE 3 (SUBUNIT VP4): DHLPTX

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

E
1

I
1

M
1

Q
1

U
1

B
2

F
2

J
2

N
2

R
2

V
2

C
3

G
3

K
3

O
3

S
3

W
3

D
4

H
4

L
4

P
4

T
4

X
4

POLIOVIRUS TYPE 3 (SUBUNIT VP1)

POLIOVIRUS TYPE 3 (SUBUNIT VP2)

POLIOVIRUS TYPE 3 (SUBUNIT VP3)

POLIOVIRUS TYPE 3 (SUBUNIT VP4)

Related Entries With Identical Sequence